We use cookies for a better user experience. Read our Privacy Policy

I Agree

Global Immunoassay Instruments Market to Reach US$23.3 bn by 2020, Propelled by Increasing Incidence of Chronic Diseases

Healthcare |

Transparency Market Research has published a new report on the global immunoassay instruments market. As per the report, the global immunoassay instruments market had a valuation of US$13.5 bn in 2013. The report, titled ‘Immunoassay Instruments Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020,’ states that the global market is predicted to expand at an 8.10% CAGR from 2014 to 2020 to reach US$23.3 bn by 2020. 

Browse the full Immunoassay Instruments Market (Product: Chemiluminescence (CLI), Immunofluorescence (IFA) & Radioimmunoassay (RIA) Analyzers, Enzyme Linked Fluorescence (ELFA) & Multiplexed Assay Systems, Enzyme Immunoassay Instruments; Application: Oncology, Endocrinology, Infectious Diseases, Therapeutic Drug Monitoring, Cardiology, Autoimmune Disorders & Drugs of Abuse) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 report at https://www.transparencymarketresearch.com/immunoassay-instruments-market.html

The increasing rate of HIV infections and the increasing incidence of chronic diseases will benefit this market, states the report. Over the past few years, a growing pool of obese people have been diagnosed with diabetes. As per the World Health Organization, currently, there are approximately 347 million individuals worldwide suffering from diabetes. Many medical centers and laboratories use immunoassay tests to investigate diabetes. The growing pool of diabetic people is another factor predicted to propel the global immunoassay instruments market.

An immunoassay, a lab-based diagnostic procedure, helps to diagnose various infectious diseases and disorders such as HIV, cancer, diabetes, hepatitis, and thyroid disorders. Immunoassay instruments are used to study the development of antibody-antigen complexes in body fluids such as blood samples. Immunoassays find application in cardiology, infectious diseases, oncology, endocrinology, autoimmune diseases, drugs of abuse, and therapeutic drug monitoring. The main technologies employed in immunoassays are immunofluorescence, chemiluminescent immunoassay, enzyme-linked immunosorbent assay (ELISA), radioimmunoassay, and enzyme-linked fluorescence.

The growing use of immunoassay instruments for clinical and environmental testing in clinical laboratories and hospitals is predicted to benefit the global market in the next five years. Factors such as the constant introduction of new medical devices and the rising demand for effective immunoassays are expected to propel the worldwide market for immunoassay instruments. The global immunoassay instruments market has registered significant growth in the recent past and is expected to witness an upward growth trend in the near future.

The global immunoassay instruments market is segmented on the basis of product type, application, and geography. Based on product type, the global market is classified into chemiluminescence (CLI) analyzers, immunofluorescence (IFA) analyzers, enzyme immunoassay instruments, radioimmunoassay analyzers, enzyme-linked fluorescent systems, and multiplexed assay systems.

The rising preference for customized medicines is expected to create new opportunities in the global immunoassay instruments market. Technical advancements in the discovery of biomarkers are also expected to drive the demand for immunoassay instruments globally. However, the high production cost of technologically advanced immunoassay systems is expected to hamper the global immunoassay instruments market in the near future.

Some of the leading players operating in this global market are Abbott Laboratories, DiaSorin S.p.A, Roche Diagnostics, bioMerieux, Siemens Healthcare, and Thermo Fisher Scientific. Leading players in the global market are concentrating on developing reliable and compact immunoassay instruments.

The global immunoassay instruments market is geographically spread across North America, Europe, Asia Pacific, and Rest of the World. Leading manufacturers of immunoassay instruments are focusing on innovations to gain competitiveness. In 2013, North America dominated the global immunoassay instruments market, followed by Europe.

Key Segments of Global Immunoassay Instruments Market

Immunoassay Instruments Market, by Product Type

  • Chemiluminescence (CLI) Analyzers
  • Immuno Fluorescence (IFA) Analyzers
  • Enzyme Immunoassay Instruments
  • Radioimmunoassay Analyzers
  • Enzyme Linked Fluorescent Systems
  • Multiplexed Assay Systems

Immunoassay Instruments Market, by Application

  • Endocrinology
  • Oncology
  • Infectious Diseases
  • Cardiology
  • Therapeutic Drug Monitoring
  • Autoimmune Diseases
  • Drugs of Abuse

Immunoassay Instruments Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.


Mr.Sudip S
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

Copyright © Transparency Market Research, Inc. All Rights reserved